{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:56:48Z","timestamp":1792112208741,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["#1061418"],"award-info":[{"award-number":["#1061418"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["#1061419"],"award-info":[{"award-number":["#1061419"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.drudis.2019.03.029","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T18:48:16Z","timestamp":1554403696000},"page":"1598-1605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Targeting P2X7 receptors as a means for treating retinal disease"],"prefix":"10.1016","volume":"24","author":[{"given":"Erica L.","family":"Fletcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7827-3135","authenticated-orcid":false,"given":"Andrew I.","family":"Jobling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew V.","family":"Rutar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1028-648X","authenticated-orcid":false,"given":"Ursula","family":"Greferath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1031-1964","authenticated-orcid":false,"given":"Kirstan A.","family":"Vessey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2019.03.029_bib0005","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990\u20132020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.drudis.2019.03.029_bib0010","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2019.03.029_bib0015","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","article-title":"Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP)","volume":"120","author":"Rofagha","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.drudis.2019.03.029_bib0020","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/pr.110.003129","article-title":"Activation and regulation of purinergic P2X receptor channels","volume":"63","author":"Coddou","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.drudis.2019.03.029_bib0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fncel.2015.00389","article-title":"Vesicular expression and release of ATP from dopaminergic neurons of the mouse retina and midbrain","volume":"9","author":"Ho","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.drudis.2019.03.029_bib0030","first-page":"385","article-title":"The inflammasome pathway is amplified and perpetuated in an autocrine manner through connexin43 hemichannel mediated ATP release","volume":"3","author":"Mugisho","year":"1862","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.drudis.2019.03.029_bib0035","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.ajpath.2017.04.016","article-title":"Loss of function of P2X7 receptor scavenger activity produces an early age related macular degeneration phenotype in mice","volume":"187","author":"Vessey","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.drudis.2019.03.029_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029990","article-title":"Rod and cone pathway signalling is altered in the P2X7 receptor knock out mouse","volume":"7","author":"Vessey","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2019.03.029_bib0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11302-009-9142-6","article-title":"The P2X(7) receptor in retinal ganglion cells: a neuronal model of pressure-induced damage and protection by a shifting purinergic balance","volume":"5","author":"Mitchell","year":"2009","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.drudis.2019.03.029_bib0050","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.4049\/jimmunol.1101178","article-title":"P2X(7) is a scavenger receptor for apoptotic cells in the absence of its ligand, extracellular ATP","volume":"187","author":"Gu","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2019.03.029_bib0055","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22153","article-title":"Structural basis for subtype-specific inhibition of the P2X7 receptor","volume":"5","author":"Karasawa","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.drudis.2019.03.029_bib0060","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.tcb.2018.01.005","article-title":"The elusive P2X7 macropore","volume":"28","author":"Di Virgilio","year":"2018","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.drudis.2019.03.029_bib0065","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/pr.113.008003","article-title":"The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease","volume":"66","author":"Bartlett","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.drudis.2019.03.029_bib0070","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/eye.2017.241","article-title":"Inflammasomes, the eye and anti-inflammasome therapy","volume":"32","author":"Yerramothu","year":"2018","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.drudis.2019.03.029_bib0075","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1093\/emboj\/20.22.6347","article-title":"Proteomic and functional evidence for a P2X7 receptor signalling complex","volume":"20","author":"Kim","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.drudis.2019.03.029_bib0080","doi-asserted-by":"crossref","first-page":"C430","DOI":"10.1152\/ajpcell.00079.2009","article-title":"Extracellular ATP dissociates nonmuscle myosin from P2X(7) complex: this dissociation regulates P2X(7) pore formation","volume":"297","author":"Gu","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.drudis.2019.03.029_bib0085","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1182\/blood-2009-11-251744","article-title":"The P2X7-nonmuscle myosin membrane complex regulates phagocytosis of nonopsonized particles and bacteria by a pathway attenuated by extracellular ATP","volume":"115","author":"Gu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.03.029_bib0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1074\/jbc.M006781200","article-title":"Altered cytokine production in mice lacking P2X(7) receptors","volume":"276","author":"Solle","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2019.03.029_bib0095","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0169-328X(98)00254-X","article-title":"Expression of the P2X7-receptor subunit in neurons of the rat retina","volume":"62","author":"Brandle","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.drudis.2019.03.029_bib0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/cne.20045","article-title":"Synaptic localization of P2X7 receptors in the rat retina","volume":"472","author":"Puthussery","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.drudis.2019.03.029_bib0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1460-9568.2006.04895.x","article-title":"Evidence for the involvement of purinergic P2X receptors in outer retinal processing","volume":"24","author":"Puthussery","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drudis.2019.03.029_bib0110","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1523\/JNEUROSCI.20-16-05965.2000","article-title":"P2X7 receptors in Muller glial cells from the human retina","volume":"20","author":"Pannicke","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2019.03.029_bib0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0079-6123(01)32080-0","article-title":"Calcium signaling in retinal glial cells and its effect on neuronal activity","volume":"132","author":"Newman","year":"2001","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.drudis.2019.03.029_bib0120","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1096\/fj.12-215368","article-title":"A rare functional haplotype of the P2RX4 and P2RX7 genes leads to loss of innate phagocytosis and confers increased risk of age-related macular degeneration","volume":"27","author":"Gu","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.drudis.2019.03.029_bib0125","doi-asserted-by":"crossref","first-page":"36217","DOI":"10.7554\/eLife.36217","article-title":"Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody","volume":"7","author":"Kaczmarek-Hajek","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.drudis.2019.03.029_bib0130","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1523\/JNEUROSCI.2812-04.2004","article-title":"ATP-induced non-neuronal cell permeabilization in the rat inner retina","volume":"24","author":"Innocenti","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2019.03.029_bib0135","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.drudis.2019.03.029_bib0140","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nm1082","article-title":"P2X7 receptor inhibition improves recovery after spinal cord injury","volume":"10","author":"Wang","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2019.03.029_bib0145","doi-asserted-by":"crossref","first-page":"8319","DOI":"10.1167\/iovs.14-15732","article-title":"ATP-induced photoreceptor death in a feline model of retinal degeneration","volume":"55","author":"Aplin","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2019.03.029_bib0150","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/cne.21964","article-title":"Extracellular ATP induces retinal photoreceptor apoptosis through activation of purinoceptors in rodents","volume":"513","author":"Puthussery","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.drudis.2019.03.029_bib0155","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1002\/cne.23558","article-title":"Adenosine triphosphate-induced photoreceptor death and retinal remodeling in rats","volume":"522","author":"Vessey","year":"2014","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.drudis.2019.03.029_bib0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053338","article-title":"Dynamic increase in extracellular ATP accelerates photoreceptor cell apoptosis via ligation of P2RX7 in subretinal hemorrhage","volume":"8","author":"Notomi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2019.03.029_bib0165","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.exer.2011.06.020","article-title":"Sustained elevation of extracellular ATP in aqueous humor from humans with primary chronic angle-closure glaucoma","volume":"93","author":"Li","year":"2011","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.drudis.2019.03.029_bib0170","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1167\/iovs.14-15891","article-title":"Rat, mouse, and primate models of chronic glaucoma show sustained elevation of extracellular ATP and altered purinergic signaling in the posterior eye","volume":"56","author":"Lu","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2019.03.029_bib0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fnins.2017.00041","article-title":"Characterization of the circumlimbal suture model of chronic IOP elevation in mice and assessment of changes in gene expression of stretch sensitive channels","volume":"11","author":"Zhao","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.drudis.2019.03.029_bib0180","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1167\/iovs.05-0052","article-title":"Stimulation of P2X7 receptors elevates Ca2+ and kills retinal ganglion cells","volume":"46","author":"Zhang","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2019.03.029_bib0185","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.exer.2010.06.017","article-title":"Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo","volume":"91","author":"Hu","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.drudis.2019.03.029_bib0190","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1111\/j.1460-9568.2007.05528.x","article-title":"Acute retinal ganglion cell injury caused by intraocular pressure spikes is mediated by endogenous extracellular ATP","volume":"25","author":"Resta","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drudis.2019.03.029_bib0195","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1167\/iovs.09-3816","article-title":"Altered calcium signaling in an experimental model of glaucoma","volume":"51","author":"Niittykoski","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2019.03.029_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031991","article-title":"Genetic ablation of Pannexin1 protects retinal neurons from ischemic injury","volume":"7","author":"Dvoriantchikova","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2019.03.029_bib0205","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1523\/JNEUROSCI.3955-14.2015","article-title":"Upregulation of P2RX7 in Cx3cr1-deficient mononuclear phagocytes leads to increased interleukin-1beta secretion and photoreceptor neurodegeneration","volume":"35","author":"Hu","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2019.03.029_bib0210","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.preteyeres.2017.06.002","article-title":"On phagocytes and macular degeneration","volume":"61","author":"Guillonneau","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.drudis.2019.03.029_bib0215","first-page":"431","article-title":"Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes","volume":"18","author":"Chua","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.drudis.2019.03.029_bib0220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1167\/iovs.11-8434","article-title":"Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract","volume":"53","author":"Takai","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2019.03.029_bib0225","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/annrheumdis-2011-143578","article-title":"Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","volume":"71","author":"Keystone","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.drudis.2019.03.029_bib0230","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3899\/jrheum.110874","article-title":"Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate","volume":"39","author":"Stock","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.drudis.2019.03.029_bib0235","first-page":"2247","article-title":"Safety and efficacy of an oral inhibitor of the purinergic receptor P2X7 in adult patients with moderately to severely active Crohn\u2019s disease: a randomized placebo-controlled, double-blind, Phase IIa study","volume":"21","author":"Eser","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.drudis.2019.03.029_bib0240","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/s41386-018-0141-6","article-title":"Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia","volume":"43","author":"Bhattacharya","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drudis.2019.03.029_bib0245","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/0269881118800067","article-title":"Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants","volume":"32","author":"Timmers","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drudis.2019.03.029_bib0250","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bbadis.2018.01.012","article-title":"The scavenger activity of the human P2X7 receptor differs from P2X7 pore function by insensitivity to antagonists, genetic variation and sodium concentration: relevance to inflammatory brain diseases","volume":"1864","author":"Ou","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.drudis.2019.03.029_bib0255","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf8463","article-title":"Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation","volume":"8","author":"Danquah","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drudis.2019.03.029_bib0260","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/sj.bjp.0701081","article-title":"The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes","volume":"120","author":"Gargett","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2019.03.029_bib0265","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.bjp.0707265","article-title":"Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states","volume":"151","author":"Donnelly-Roberts","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2019.03.029_bib0270","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neuropharm.2008.06.012","article-title":"[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors","volume":"56","author":"Donnelly-Roberts","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drudis.2019.03.029_bib0275","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.bjp.0706933","article-title":"Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373","volume":"149","author":"Stokes","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2019.03.029_bib0280","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1124\/jpet.114.218487","article-title":"Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432","volume":"351","author":"Lord","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2019.03.029_bib0285","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00401-016-1596-3","article-title":"Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer\u2019s disease","volume":"132","author":"Gu","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.drudis.2019.03.029_bib0290","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1016\/j.bmcl.2010.07.033","article-title":"Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor","volume":"20","author":"Abdi","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2019.03.029_bib0295","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2125.2012.04320.x","article-title":"Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects","volume":"75","author":"Ali","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drudis.2019.03.029_bib0300","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1021\/acs.jmedchem.7b00408","article-title":"4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-based P2X7 receptor antagonists: optimization of pharmacokinetic properties leading to the identification of a clinical candidate","volume":"60","author":"Letavic","year":"2017","journal-title":"J. Med. Chem."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644618303908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644618303908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:40:28Z","timestamp":1761223228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644618303908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1359644618303908"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2019.03.029","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting P2X7 receptors as a means for treating retinal disease","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2019.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}